Today's focus

[Kweichow Moutai: Net profit of 41.696 billion yuan in the first half of the year increased 15.88% year over year]

Kweichow Moutai announced that in the first half of the year, the company achieved operating income of 81.931 billion yuan, an increase of 17.76% year on year; net profit attributable to shareholders of listed companies was 41.696 billion yuan, an increase of 15.88% year on year. Among them, Maotai liquor achieved revenue of 68.567 billion yuan, and serial wine achieved revenue of 13.147 billion yuan. Through the “iMaotai” digital marketing platform, the company achieved income of 10.25 billion yuan without tax from alcohol. At the end of the reporting period, the company's total assets were 279.207 billion yuan, an increase of 2.39% over the end of the previous year. Small financial note: Q1 net profit of 24.065 billion yuan. Based on this calculation, Q2 net profit was 17.63 billion yuan, down 27% from the previous month.

[Kweichow Moutai: The total amount of cash dividends distributed each year in 2024-2026 shall not be less than 75% of the net profit for that year]

Kweichow Moutai announced that in order to continuously enhance investor returns, the company's board of directors has drawn up a 2024-2026 cash dividend return plan. According to the plan, the total amount of cash dividends distributed by the company each year is not less than 75% of the net profit attributable to shareholders of listed companies in the current year, and the annual cash dividends are implemented twice (annual and mid-term dividends). The specific cash dividend plan is drawn up by the board of directors of the company and implemented after review and approval by the company's shareholders' meeting. The plan is drawn up and revised by the board of directors and implemented after review and approval by the company's shareholders' meeting.

[3-board Northeast Pharmaceutical: Dingcheng Peptide Source's product pipeline is in the pre-clinical R&D and clinical declaration stages without substantial revenue]

Northeast Pharmaceutical issued a change announcement, and there is uncertainty about the acquisition of 70% of Dingcheng Peptide Source's shares. Up to now, Dingcheng Peptide Source's product pipeline is in the pre-clinical development and clinical declaration stage. At this stage, the company has no substantial income, is in a state of operating loss, and its net assets are also negative. Since Dingcheng's new peptide-derived drug has not yet been approved for marketing, and there is no authorization to sell related pipeline products or molecular sequences, it has failed to generate revenue.

[Yongtai Energy: Progress has been made in expanding high-quality coking coal resources in affiliated coal mines and is expected to increase the company's total net profit by about 3 billion yuan]

Yongtai Energy announced that high-quality coking coal border resources around the company's Sunyi Coal Mine, Mengziyu Coal Mine, and Jintaiyuan Coal Mine have met the expansion conditions. Among them, the Sunyi coal mine plans to expand its resources by about 7.15 million tons, the Mengziyu coal mine plans to expand its resources by about 5.87 million tons, and the Jintaiyuan coal mine plans to expand its resources by about 6.73 million tons. In total, it is planned to expand the resources by about 19.75 million tons. The company has reported the relevant application materials to the Shanxi Provincial Department of Natural Resources and has initiated the concession process. This resource expansion is expected to increase the company's high-quality coking coal resources by 19.75 million tons, and is expected to increase the company's total net profit by about 3 billion yuan (calculated based on the company's current average net profit of about 200 yuan/ton per ton of coal mining business and additional recoverable reserves), which will further enhance the company's overall operating performance.

[ST Dongshi: Xu Xiong, the actual controller of the company, received a notice from the China Securities Regulatory Commission]

ST Dongshi announced that Xu Xiong, the actual controller of the company, received the “Notice of Case Filing” issued by the China Securities Regulatory Commission on August 7, 2024, and a case was opened and investigated for suspected illegal disclosure of information. Xu Xiong was approved for arrest in 2023 on suspicion of manipulating the securities market. Xu Jinsong, chairman of the company, has been commissioned to handle related matters on his behalf. The company's business activities are currently being carried out normally.

[Yongtai Energy: Signed a bank-enterprise cooperation agreement totaling 3.5 billion yuan]

Yongtai Energy announced that in order to guarantee the company's production and operation, key project construction and high-quality development, and promote joint development and long-term cooperation between banks and enterprises based on the principles of mutual benefit, mutual support and win-win, the company signed bank-enterprise cooperation agreements with the Bank of Shanxi and Jinshang Bank respectively to provide the company and its affiliated companies with no more than 2 billion yuan and 1.5 billion yuan, respectively, for a total of no more than 3.5 billion yuan in total credit support.

[Cambridge Technology: Net profit fell 48.69% year-on-year in the first half of the year]

Cambridge Technology released its 2024 semi-annual report. During the reporting period, the company achieved revenue of 1.762 billion yuan, an increase of 1.31% over the previous year. Net profit attributable to shareholders of listed companies was 80.0039 million yuan, a year-on-year decrease of 48.69%. The company plans to pay a cash dividend of 0.3 yuan (tax included) for every 10 shares. Small financial note: Q1 net profit of 25.9547 million yuan. Based on this calculation, Q2 net profit was 54.0492 million yuan, an increase of 108% over the previous month.

[14 days 9 board Guozhong Water: Beijing Huiyuan holds some of the assets under the original Huiyuan Group, including ownership of all “Huiyuan” brands and trademarks]

Guozhong Water revealed abnormal stock trading fluctuations. Beijing Huiyuan held some of the assets under the original Huiyuan Group, including all “Huiyuan” brand and trademark ownership, all sales channels, Shunyi factory, and 15 own production lines. After the restructuring was implemented, the orchard planting base and most of the production lines are still under the former Huiyuan Group. Beijing Huiyuan currently uses an asset-light operation model and still mainly focuses on contract manufacturing. Investors are kindly requested to make careful decisions and pay attention to investment risks.

[Guangdong Construction Engineering: Signed a strategic cooperation framework agreement for a 14 billion yuan wind power hydrogen production integration project to synthesize green methanol]

Guangdong Construction Engineering announced that Guangdong Hydropower Energy Group, a subsidiary of the company, signed a “Strategic Cooperation Framework Agreement” with the Huanan County People's Government in Jiamusi City, Heilongjiang Province, Heilongjiang Hongzhan Biotechnology Co., Ltd. and Jiangsu Dafu Integrated Equipment Technology Co., Ltd. for the integrated project of wind power hydrogen production to produce green methanol. The total investment of the project is about 14 billion yuan, and it is planned to build a green methanol project with an annual output of 0.5 million tons. It is currently in the early stages of preparation and is not expected to have a significant impact on the company's business performance in 2024.

[China Mobile: Net profit of 80.2 billion yuan in the first half of 2024 increased 5.3% year over year]

China Mobile announced that in the first half of 2024, the company's revenue was 546.7 billion yuan, up 3.0% year on year. Net profit attributable to shareholders of the parent company was 80.2 billion yuan, up 5.3% year over year. The company decided to pay HK$2.60 per share in the mid-term of 2024, an increase of 7.0% over the previous year. Small financial note: Q1 net profit of 29.609 billion yuan. Based on this calculation, Q2 net profit was 50.592 billion yuan, an increase of 71% over the previous month.

[5-board central shopping mall: there is a risk that the company's stock price will fall back after a sharp rise in stock price]

The Central Mall issued a stock trading risk warning notice. Since August 1, 2024, the company's stock price has increased by 61.6%. Today, the closing price of the company's stock is 3.83 yuan/share, and the turnover rate is 17.82%. Recently, the company's stock price has risen significantly in the short term, and the turnover rate is high, but there have been no major changes in the company's fundamentals. There may be irrational hype, etc., and there may be a risk that the stock price will fall back after a sharp rise.

Investments & Contracts

[Linglong Tire: Plans to invest 0.645 billion US dollars to carry out overseas (Serbia) investment expansion projects]

Linglong Tire announced that the company decided to launch an overseas (Serbia) investment expansion project, with a total investment of 645.3803 million US dollars (4620.6 million yuan off). After completion, the project will produce 1.1 million sets of high-performance radial tires per year and build a 24MW photovoltaic power plant. The company said that this project is of great significance in comprehensively enhancing the company's core competitiveness and increasing market share. At the same time, the company reminds that there is a risk that plans and forecasts such as investment progress, construction period, and payback period will not be progressed and realized as scheduled.

[Great Wall Technology: Plans to build a new production base in Thailand]

Great Wall Technology announced that the company plans to invest in a new production base in Thailand. The planned investment amount for this project is no more than 60 million US dollars.

Increase/decrease holdings & repurchases

[Liuhua Shares: Shareholders plan to reduce their holdings of the company by no more than 3%]

Liuhua Co., Ltd. announced that CCB Guangxi Branch, the shareholder holding 5% or more of the company's shares, and the co-actor Jianxin Financial Leasing Plan to reduce the total holdings of the company's shares by no more than 23.96 million shares, that is, the amount of holdings reduced by no more than 3% of the company's total share capital.

[Shaanxi Black Cat: Actual controller Li Baoping plans to increase the company's stock holdings by 0.1 billion yuan]

Shaanxi Black Cat announced that the actual controller, Li Baoping, plans to increase his holdings of the company's shares within 6 months from the date of disclosure of the announcement through methods permitted by the China Securities Regulatory Commission and the Shanghai Stock Exchange. The amount of increase in holdings is RMB 100 million. Li Baoping currently directly holds 47,320,000 shares of the company, accounting for 2.32% of the company's total share capital. There is a risk that this plan to increase holdings will be delayed or not implemented due to factors such as changes in capital market conditions.

[Yuanzu shares: Zhuhai Lanxin Growth and its co-actors plan to reduce the company's shares by no more than 7.2 million shares]

Yuanzu Co., Ltd. announced that due to its own capital requirements, Zhuhai Lanxin Growth Consulting Management Partnership (Limited Partnership) and Lanxin Investment Consulting (Tianjin) Co., Ltd. plan to reduce the company's shares by no more than 7.2 million shares through centralized bidding and bulk transactions, that is, no more than 3% of the company's total share capital. Among them, where holdings are reduced through centralized bidding, it is intended to be carried out within 3 months after 15 trading days from the date of disclosure of the announcement, and the amount of holdings reduction shall not exceed 1% of the total number of shares of the company; where holdings are reduced through bulk transactions, it is proposed to be carried out within 3 months after 15 trading days from the date of disclosure of the announcement, and the amount of holdings reduction shall not exceed 2% of the total number of shares of the company.

[Oujing Technology: Wan Zhaohuigu, a shareholder holding 5% or more, plans to reduce the company's shares by no more than 1%]

Oujing Technology announced that Tianjin Wanzhaohuigu Real Estate Co., Ltd. (Wanzhaohuigu), a shareholder holding 5% or more of the shares, plans to reduce the total holdings of the company's shares by no more than 1.924 million shares through bulk transactions within 3 months after 15 trading days from the date of disclosure of this announcement, that is, no more than 1% of the company's total share capital. The reason for the reduction in holdings was due to the company's own operating needs. The source of the reduction in holdings was shares acquired by the company before its initial public offering.

Operation & Performance

[Alto Electronics: Net profit decreased 87.08% year on year in the first half of the year]

Alto Electronics announced that in the first half of 2024, the company achieved revenue of 0.333 billion yuan, an increase of 3.59% over the previous year. Net profit attributable to shareholders of listed companies was 2.3656 million yuan, a year-on-year decrease of 87.08%.

[Happy Healthcare: Net profit increased 303.72% year-on-year in the first half of the year, and plans to split 10 to 1.3 yuan]

Lexin Medical announced that in the first half of 2024, the company achieved operating income of 0.499 billion yuan, a year-on-year increase of 29.63%; net profit attributable to shareholders of listed companies was 34.85 million yuan, an increase of 303.72% over the previous year. The company plans to distribute a cash dividend of 1.3 yuan for every 10 shares to all shareholders based on 216,023,988 shares.

[Nanxin Technology: Net profit increased 103.86% year-on-year in the first half of the year and plans to distribute 1 yuan for every 10 shares]

Nanxin Technology released a summary of the 2024 semi-annual report. During the reporting period, the company achieved operating income of 1,250,095,791.84 yuan, an increase of 89.28% over the previous year; net profit attributable to shareholders of listed companies was 205,153,757.07 yuan, an increase of 103.86% over the previous year. The company plans to distribute a cash dividend of 1 yuan (tax included) to all shareholders for every 10 shares based on the total share capital registered on the share registration date of implementation of equity distribution minus the number of shares held by the special repurchase account.

Contract & Project Bid Winning

[Construction research and design: 5.28 billion Yuqiao Ecological Technology Industrial Park project contract signed]

According to the construction research and design announcement, the company signed a “General Contracting Contract for the Construction Project” for the “Yuqiao Ecological Technology Industrial Park and Yuqiao Lake and Chuhe River Main Canal Ecological Comprehensive Treatment Project” with the consortium members. The contract price was 5.28 billion yuan, and the company's design fee in the consortium was about 74 million yuan.

[Haimu Star: Won the bid for 1.25 billion yuan overseas project]

Hymstar announced that the company recently received a notice of winning bid from a leading overseas car company. The winning bid amount was approximately RMB 1.25 billion. As of the announcement disclosure date, contracts have been signed for all projects. This is a reflection of the phased results of the company's overseas strategic layout. It is also a recognition of the company's R&D capabilities, technical strength and equipment quality by overseas customers. At the same time, the company indicated revenue recognition time, industry development risks, and exchange rate fluctuations.

Financing & fixed growth

[International Industry: Proposed capital increase of no more than 0.665 billion yuan from controlling shareholders]

International Industrial announced that the company plans to issue shares to Jiangsu Rongneng, the controlling shareholder, at a price of 4.61 yuan/share, and raise no more than 0.665 billion yuan, all of which will be used to supplement working capital.

Stock price changes

[Qianzhao Optoelectronics: There have been no major changes in the current business situation and business environment]

Qianzhao Optoelectronics announced that the company is concerned about the recent strengthening of commercial space concepts in the market, and some listed companies in the sector, including companies, have increased significantly. According to the company's 2023 annual report, the company is a leading domestic supplier of gallium arsenide solar cell epitaxial wafers. Shipments in 2023 have increased significantly compared to the previous year. Currently, the specific demand situation follows fluctuations in customer orders, and there is uncertainty. There is also uncertainty about the contribution of these products to sales or profit this year. Furthermore, the company did not find any other media reports, market rumors, or hot concepts that could have a significant impact on the trading price of the company's shares. The company's current business situation and internal and external business environment have not changed significantly.

[World Bank: Current business conditions are normal]

The World Bank issued a change notice. The company verified the relevant matters and questioned the controlling shareholders and actual controllers. The current business situation of the company is normal, and there have been no major changes in the internal and external business environment. The company, controlling shareholders and actual controllers have no important matters that should be disclosed but not disclosed or are in the planning stage.

other

[Jimin Healthcare: Stock abbreviation will be changed to “Jimin Health”]

Jimin Medical announced that the company plans to change the stock abbreviation from “Jimin Medical” to “Jimin Health”, and the stock code “603222” remains unchanged. The company held a board meeting on July 30, 2024 to review and pass the proposed change. This change will be officially implemented on August 13, 2024.

[Shuoshi Biotech: The company has monkeypox virus nucleic acid detection kits in its product line]

Some investors asked Shuoshi Biotech about the recent spread of monkeypox virus infections around the world. Does the company have corresponding product reserves for monkeypox virus testing? Shuoshi Biotech said on an interactive platform that the company's product line includes a monkeypox virus nucleic acid detection kit (fluorescence PCR method). The product obtained EU CE certification and UK MHRA registration in 2022. It is sold domestically in the disease control and research markets, and has not had a significant impact on the company's current revenue and profits.